生物膜
抗生素
化学
微生物学
药物输送
氧化应激
药品
角膜炎
辅因子
渗透(战争)
脱氧核糖核酸酶
抗药性
光敏剂
氧化磷酸化
细菌
胞外聚合物
抗生素耐药性
抗菌剂
酶
生物物理学
活性氧
生物化学
核酸酶
细胞外
流出
DNA
生产过剩
毒品携带者
作者
Ruixiao Wang,Yan Song,Junjia Zeng,Qinxian Ma,Lu Zhou,Shuo Du,Mengzhen Wang,Lingwan Hao,Rujian Jiang,Xiaolin Qi
摘要
ABSTRACT Biofilm‐associated infections remain refractory to antibiotics due to the extracellular polymeric substance (EPS) barrier limiting drug penetration and promoting drug resistance genes transfer. Deoxyribonuclease I (DNase I)‐based strategies designed to degrade the EPS scaffold paradoxically fail within the biofilm microenvironment, where oxidative stress rapidly deactivates the enzyme and its cleavage efficiency remains intrinsically low. Here, we developed a self‐reinforced nanosystem (D‐HIC) by integrating MnO 2 (HMnO 2 ) with DNase I and co‐loading indocyanine green and ciprofloxacin, simultaneously addressing the intrinsic limitations of enzyme‐based therapies. Crucially, HMnO 2 catalyzed the excess ROS to protect DNase I from oxidative degradation, and this catalytic process is accompanied by the generation of Mn 2+ which was found to significantly accelerate DNase I‐mediated EPS cleavage by nearly fourfold to achieve rapid biofilm skeleton disruption. This potentiation created rapid penetration channels, enabling deep delivery of loadings for near‐infrared‐triggered complete biofilm elimination and remarkable bacterial killing rate (>99%) at reduced antibiotic doses. In a murine bacterial keratitis model, this strategy achieved superior therapeutic outcomes compared to clinical eye drops. By coupling oxidative stress relief with catalytic cofactor generation from a single material platform, this work establishes a versatile strategy that overcomes the fundamental limitations of traditional enzyme‐based antibiofilm approaches.
科研通智能强力驱动
Strongly Powered by AbleSci AI